Philips CPAP Recall Lawsuit

Medical device manufacturer, Phillips Respironics has issued a recall for millions of its DreamStation CPAP sleep apnea and other breathing machines due to an increased risk of lung injury. People who experienced lung injury or cancer after using a Phillips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), or mechanical ventilator device may be eligible for compensation through a Philips CPAP lawsuit.

Free Case Evaluation
Jump to topic
  • Philips CPAP Breathing Machines Recalled Over Potential Lung Injury
  • Philips CPAP Recall Updated
  • Recalled Philips Devices Named
  • Sound-reducing Foam Liner May Be to Blame
  • Symptoms of Exposure to Degradation of Philips Breathing Machines
  • Philips CPAP Lung Injury Lawsuit

Philips CPAP Breathing Machines Recalled Over Potential Lung Injury

Millions of Philips Respironics breathing machines have been recalled due to a potential risk of lung injury. Phillips has issued a recall for Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices over concerns that the foam liners may disintegrate or outgas, potentially resulting in inhalation of contaminants and/or toxic chemicals.

Philips may be facing multiple lawsuits filed by people who experienced injury or cancer after using a Philips sleep apnea CPAP, Bi-level PAP, or mechanical ventilator.

Philips CPAP Recall Updated

An initial Philips Sleep Apnea Device recall was issued in April of 2021 and has been updated as of June 2021. It is a voluntary recall which likely may be considered a Class II FDA recall but is currently listed only as a safety notification.

The recall involves millions of sleep apnea and ventilator machines, most of which are of the DreamStation, first-generation production line and are within the 5-year service life. The recall has been issued for machines which contain a sound-abatement foam comprised of polyester-based polyurethan which may degrade to release particles and chemicals which may be inhaled. Philips estimates that up to 4 million devices may be affected and has constrained the recall to the U.S. market.

Recalled Philips Devices Include:

CPAP and BiLevel PAP

Continuous Ventilator, Non-life Supporting

  • DreamStation ASV
  • DreamStation ST, AVAPS
  • SystemOne ASV4
  • C Series ASV, S/T, AVAPS
  • OmniLab Advanced Plus In-Lab Titration Device

Non-continuous Ventilator

  • SystemOne Q series
  • DreamStation CPAP, Auto CPAP, BiPAP
  • DreamStation Go CPAP, APAP
  • Dorma 400, 500 CPAP
  • REMStar SE AutoCPAP

Continuous Ventilator, Minimum Ventilatory Support, Facility Use

  • E30 (Under Emergency Use Authorization)

Mechanical Ventilators

Continuous Ventilator

  • Trilogy 100Ventilator
  • Trilogy 200Ventilator
  • Garbin Plus, Aeris, LifeVent Ventilator

Continuous Ventilator, Minimum Ventilatory Support, Facility Use

  • A-Series BiPAP V30 AutoVentilator

Sound-reducing Foam Liner May Be to Blame

The June 2021 Philips Respironics CPAP and ventilator recall has been issued due to a possibility of increased risk of airway contamination or inhalation of particles or chemicals. The effects on the user may include lung injury, chemical exposure, and possible increase in cancer risk.

Risks of lung injury and cancer are related to polyester-based polyurethane (PE-PUR) foam which is a sound-abatement foam component of certain models of the devices. PE-PUR foam may degrade into particles, entering into the device air pathway, to be inhaled or ingested. In addition, the foam may also be prone to “off-gas” chemicals which may be toxic. The degradation and outgassing may be worsened by the use of unapproved cleaning methods including high heat, high humidity, and ozone cleaning environments.

Exposure to Degradation of Philips Breathing Machines

The potential degradation of PE-PUR foam may lead to inhalation of degradation products and toxic chemicals. This may increase the chance of lung injury and may also increase the risk of cancer.

Symptoms of exposure may include:

  • Headache
  • Throat irritation
  • Coughing
  • Lung inflammation
  • Nausea and vomiting
  • Carcinogenic effects

Philips CPAP Lung Injury Lawsuit

People who have suffered:

  • Airway irritation or inflammation
  • Breathing difficulty
  • Lung Damage
  • New or worsening asthma
  • Pneumonia
  • Lung cancer
  • Kidney cancer
  • Liver cancer
  • Colon cancer
  • Heart attack/heart failure
  • Stroke
  • Respiratory failure
  • Liver disease
  • Kidney disease

after using a Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP) or mechanical ventilator device may be eligible for compensation and should seek legal assistance.

Sources:

FREE CASE EVALUATION

Since its establishment in 1999, Seeger Weiss has led some of the most complex and high-profile litigations in the U.S.